- Home
- MRKR vs JFU Comparison
MRKR vs JFU Comparison
Compare MRKR & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRKR
- JFU
- Stock Information
- Founded
- MRKR N/A
- JFU 2006
- Country
- MRKR United States
- JFU China
- Employees
- MRKR N/A
- JFU N/A
- Industry
- MRKR Biotechnology: Pharmaceutical Preparations
- JFU Finance: Consumer Services
- Sector
- MRKR Health Care
- JFU Finance
- Exchange
- MRKR Nasdaq
- JFU Nasdaq
- Market Cap
- MRKR 13.4M
- JFU 15.8M
- IPO Year
- MRKR N/A
- JFU 2019
- Fundamental
- Price
- MRKR $1.77
- JFU $1.43
- Analyst Decision
- MRKR Strong Buy
- JFU
- Analyst Count
- MRKR 3
- JFU 0
- Target Price
- MRKR $13.17
- JFU N/A
- AVG Volume (30 Days)
- MRKR 185.7K
- JFU 3.8K
- Earning Date
- MRKR 05-15-2025
- JFU 01-01-0001
- Dividend Yield
- MRKR N/A
- JFU N/A
- EPS Growth
- MRKR N/A
- JFU N/A
- EPS
- MRKR N/A
- JFU 0.09
- Revenue
- MRKR $5,696,123.00
- JFU $40,614,155.00
- Revenue This Year
- MRKR N/A
- JFU N/A
- Revenue Next Year
- MRKR $11.28
- JFU N/A
- P/E Ratio
- MRKR N/A
- JFU $14.49
- Revenue Growth
- MRKR 71.53
- JFU N/A
- 52 Week Low
- MRKR $0.95
- JFU $1.01
- 52 Week High
- MRKR $5.99
- JFU $3.60
- Technical
- Relative Strength Index (RSI)
- MRKR 72.77
- JFU 56.01
- Support Level
- MRKR $1.12
- JFU $1.34
- Resistance Level
- MRKR $1.82
- JFU $1.48
- Average True Range (ATR)
- MRKR 0.17
- JFU 0.06
- MACD
- MRKR 0.06
- JFU 0.00
- Stochastic Oscillator
- MRKR 93.33
- JFU 65.79
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company generates the majority of its revenue from Loan facilitation services. All its revenues are generated from the People's Republic of China.